Erratum: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 (Oncotarget (2017) 8 (31041-31056))

Al-Jameel, W, Gou, X, Forootan, SS, Al Fayi, MS, Rudland, PS ORCID: 0000-0002-7491-0846, Forootan, FS, Zhang, J, Cornford, PA ORCID: 0000-0002-7146-9258, Hussain, SA and Ke, Y ORCID: 0000-0001-5341-8644 (2020) Erratum: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 (Oncotarget (2017) 8 (31041-31056)). Oncotarget, 11 (31). 3025-.

Text 024823R1.pdf - Published version Download (11MB)

Abstract

This article has been corrected: The following references were accidentally omitted from the published list: 54. Xu M, Joo HJ, Paik YK. Novel functions of lipid-binding protein 5 in Caenorhabditis elegans fat metabolism. J Biol Chem. 2011; 286:28111-8. https://doi.org/10.1074/jbc.M111.227165. [PubMed] 55. Pavese J, Ogden IM, Bergan RC. An orthotopic murine model of human prostate cancer metastasis. J Vis Exp. 2013; e50873. https://doi.org/10.3791/50873. [PubMed] 56. Janik P, Briand P, Hartmann NR. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res. 1975; 35:3698-704. [PubMed] 57. Thumser AE, Storch J. Characterization of a BODIPY-labeled fluorescent fatty acid analogue. Binding to fatty acid-binding proteins, intracellular localization, and metabolism. Mol Cell Biochem. 2007; 299:67-73. https://doi.org/10.1007/s11010-005-9041-2. [PubMed]

Item Type:	Article
Uncontrolled Keywords:	Urologic Diseases, Prostate Cancer, Aging, Cancer, 5.1 Pharmaceuticals, 2.1 Biological and endogenous factors, 5 Development of treatments and therapeutic interventions, 2 Aetiology, Cancer, Animals, Antineoplastic Agents, Binding, Competitive, Cell Line, Tumor, Cell Movement, Cell Proliferation, Cell Survival, Cyclobutanes, Dicarboxylic Acids, Disease Models, Animal, Disease Progression, Drug Discovery, Drug Screening Assays, Antitumor, Fatty Acid-Binding Proteins, Fatty Acids, Humans, Ligands, Male, Mice, Neoplasm Metastasis, PPAR gamma, Prostatic Neoplasms, Castration-Resistant, Protein Binding, Xenograft Model Antitumor Assays
Depositing User:	Symplectic Admin
Date Deposited:	06 Mar 2017 07:41
Last Modified:	09 Apr 2024 08:02
DOI:	10.18632/oncotarget.16055
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3006216